NeuroBo Pharmaceuticals, Inc. Made Big Gain

Tue, Sep 20, 2022 at 07:20 PM
NeuroBo Pharmaceuticals, Inc. Made Big Gain

NeuroBo Pharmaceuticals, Inc. (NRBO:NASDAQ) soared at $20.79, a gain of 42.4%. The stock got featured on our News Catalysts scanner on Thu, Sep 15, 2022 at 09:14 AM in the 'PATNERSHIP' category. From Tue, Sep 06, 2022, the stock recorded 50.00% Up Days and 45.45% Green Days

The stock spiked on Tue, Sep 13, 2022 at $63.85 with a volume of 9M+.

About NeuroBo Pharmaceuticals, Inc. (NRBO:NASDAQ)

NeuroBo Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is engaged in developing and commercializing therapies for patients with diabetic neuropathy and Alzheimer's disease. Its product candidate comprises NB-01, which is primarily focused on the development of a treatment for painful diabetic neuropathy; NB-02, which treat the symptoms of neurodegenerative diseases associated with the malfunction of a protein called tau, and with amyloid-beta plaque deposition; Gemcabene, which is focused on developing and commercializing therapies for the treatment of dyslipidemia.

Share
Get 50% Off Premium Subscription
$19.99 USD
Limited-Time Discount
$9.99 USD
monthly
Signup 7 Days Trial. No Credit Card Required!
Ever wanted to explore stocks that have recently spiked... stocks moving sideways... gaps... or other trends? You're in the right place! Check StockTreats features.